| Literature DB >> 16988823 |
Xiao-Fei Wang1, William M Cohen, Florence A Castelli, Christine Almunia, Bernard Lethé, Sandra Pouvelle-Moratille, Gaetan Munier, Dominique Charron, André Ménez, Hassan M Zarour, Pierre van der Bruggen, Marc Busson, Bernard Maillère.
Abstract
Because of the high frequency of HLA-DP4 in the Caucasian population, we have selectively delineated HLA-DP4 restricted T cell epitopes in the MAGE-A tumor antigens. We identified 12 good binders to HLA-DP4 and investigated the capacity of the seven best binders to induce in vitro specific CD4+ T cell lines from HLA-DP4 healthy donors. We found that the MAGE-A1 90-104 peptide exhibited a high and constant frequency of CD4+ T cell precursors in all the six tested donors. The MAGE-A1 268-282 peptide was found immunogenic in only two donors but with a high precursor frequency. The MAGE-A12 127-141 peptide was T cell stimulating in six different donors and induced fewer T cell lines. The peptide-specific T cell lines were stimulated by DC loaded with the lysates of cells transfected with MAGE-A1 or MAGE-A12, or loaded with the recombinant protein. We also show that the immunoreactivity of CD4+ T cell epitopes restricted to the same HLA II molecule may vary from one individual to another, as a result of inter-individual variations in the CD4+ T cell repertoire.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16988823 DOI: 10.1007/s00262-006-0230-y
Source DB: PubMed Journal: Cancer Immunol Immunother ISSN: 0340-7004 Impact factor: 6.968